Burberry's stock slipped 6% leaving it down almost 50% so far this year despite a rally over the past month on takeover ...

The United States is pursuing an inquiry into Russian clients that UBS took on when it bought Credit Suisse, three people ...

The billionaire Knicks owner has quietly broken off an unusual 14-month-old partnership with Oak View Group — a rival firm co ...

Roubini, sometimes known by the moniker Dr Doom, presented in person at the UBS Australasia Conference this week. This wire ...

Swiss money manager cuts mid-2025 and end-2025 targets for MSCI China Index because of tariff uncertainties and disappointing ...

Shares of Altimmune (NASDAQ:ALT) rallied 30% in afternoon trading after the company issued several business updates along ...

UBS Global Wealth Management has cut its forecast for Chinese equities due to rising concerns over potential US tariffs and a ...

Michael Lasser, UBS retail analyst, joins 'Squawk on the Street' to discuss if warm weather impacted Home Depot's quarterly ...

UBS analyst Eliana Merle initiated coverage of Altimmune (ALT) with a Buy rating and $26 price target The firm sees Altimmune as “highly ...

The U.S. Federal Reserve could carry out fewer rate cuts than previously expected next year should President-elect Donald ...

Despite Monday's pullback from record highs, analysts remain bullish on Nvidia's AI chip dominance, raising price targets to ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...